MA45609B1 - Compositions d'acide cromoglicique pour le traitement de la dermatite - Google Patents

Compositions d'acide cromoglicique pour le traitement de la dermatite

Info

Publication number
MA45609B1
MA45609B1 MA45609A MA45609A MA45609B1 MA 45609 B1 MA45609 B1 MA 45609B1 MA 45609 A MA45609 A MA 45609A MA 45609 A MA45609 A MA 45609A MA 45609 B1 MA45609 B1 MA 45609B1
Authority
MA
Morocco
Prior art keywords
dermatitis
treatment
acid compositions
cromoglicic acid
combination
Prior art date
Application number
MA45609A
Other languages
English (en)
Other versions
MA45609A (fr
Inventor
Ricardo Palacios Peláez
Javier ALCOVER DÍAZ
David RODRÍGUEZ GIL
Fernando Pineda De La Losa
Concepción TIANA FERRER
Laura FERNÁNDEZ LORENZANA
José Ángel SÁNCHEZ GARCÍA
Marta Vicario De La Torre
Original Assignee
Nutra Essential Otc, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutra Essential Otc, S.L. filed Critical Nutra Essential Otc, S.L.
Publication of MA45609A publication Critical patent/MA45609A/fr
Publication of MA45609B1 publication Critical patent/MA45609B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

<pre>La présente invention concerne une combinaison comprenant de l'acide cromoglicique ou des dérivés de celui-ci et des compositions dermatologiques comprenant ladite combinaison. L'invention concerne également l'utilisation de ladite association ou composition pour traiter la dermatite.</pre>
MA45609A 2016-07-07 2017-07-06 Compositions d'acide cromoglicique pour le traitement de la dermatite MA45609B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201630928A ES2653787B1 (es) 2016-07-07 2016-07-07 Composiciones de ácido cromoglícico para el tratamiento de la dermatitis
EP17830533.0A EP3482761B1 (fr) 2016-07-07 2017-07-06 Compositions d'acide cromoglicique pour le traitement de la dermatite
PCT/ES2017/070490 WO2018015593A1 (fr) 2016-07-07 2017-07-06 Compositions d'acide cromoglicique pour le traitement de la dermatite

Publications (2)

Publication Number Publication Date
MA45609A MA45609A (fr) 2019-05-15
MA45609B1 true MA45609B1 (fr) 2024-07-31

Family

ID=60992131

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45609A MA45609B1 (fr) 2016-07-07 2017-07-06 Compositions d'acide cromoglicique pour le traitement de la dermatite

Country Status (19)

Country Link
US (1) US20190240193A1 (fr)
EP (1) EP3482761B1 (fr)
CN (1) CN109715153A (fr)
DK (1) DK3482761T3 (fr)
ES (2) ES2653787B1 (fr)
FI (1) FI3482761T3 (fr)
HR (1) HRP20240775T1 (fr)
HU (1) HUE066913T2 (fr)
LT (1) LT3482761T (fr)
MA (1) MA45609B1 (fr)
MX (1) MX386042B (fr)
PL (1) PL3482761T3 (fr)
PT (1) PT3482761T (fr)
RS (1) RS65561B1 (fr)
RU (1) RU2754006C2 (fr)
SI (1) SI3482761T1 (fr)
SM (1) SMT202400230T1 (fr)
UA (1) UA130333C2 (fr)
WO (1) WO2018015593A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2587402B (en) * 2019-09-27 2023-05-10 Hewlett Healthcare Ltd Formulation
AU2022226676A1 (en) 2021-02-25 2023-09-28 Alphyn Biologics, Llc Composition for treatment of topical dermatological bacterial skin conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262108B1 (en) * 1997-12-03 2001-07-17 Kyoto Pharmaceutical Industries, Ltd. Medicinal use of cromoglycic acid compounds
BRPI0510906A (pt) * 2004-05-19 2007-11-06 Emisphere Tech Inc composição farmacêutica tópica, composição para administração tópica e seu uso
WO2008148572A1 (fr) * 2007-06-08 2008-12-11 Bayer Consumer Care Ag Combinaisons de principes actifs anti-inflammatoires pour le traitement de maladies de la peau et des muqueuses
RU2472499C2 (ru) * 2007-06-08 2013-01-20 Байер Конзюмер Кер АГ Лекарственное средство, включающее комбинацию активных веществ, содержащую пантотеновую кислоту или ее производные, для лечения аллергических симптомов
ES2353541B1 (es) * 2009-07-30 2011-09-20 Farmalider, S.A. Combinacion de ingredientes activos cosmeticos y composicion cosmetica obtenida a partir de la misma, y su utilizacion.
TR200907914A2 (tr) * 2009-10-20 2011-05-23 B�Lg�� Mahmut Kortlkosteroid içeren kuru toz formunda farmasötik bileşim.
IT1400386B1 (it) * 2010-05-27 2013-05-31 Roberto Logi Kit di parti per il trattamento e/o prevenzione delle ulcere cutanee

Also Published As

Publication number Publication date
UA130333C2 (uk) 2026-01-28
PT3482761T (pt) 2024-06-18
LT3482761T (lt) 2024-07-10
ES2653787A1 (es) 2018-02-08
RU2754006C2 (ru) 2021-08-25
ES2979376T3 (es) 2024-09-25
ES2653787B1 (es) 2018-09-25
SMT202400230T1 (it) 2024-07-09
EP3482761B1 (fr) 2024-04-24
RU2019103272A3 (fr) 2020-11-03
DK3482761T3 (da) 2024-05-27
MX386042B (es) 2025-03-18
WO2018015593A1 (fr) 2018-01-25
EP3482761A4 (fr) 2020-03-11
HRP20240775T1 (hr) 2024-09-13
HUE066913T2 (hu) 2024-09-28
RS65561B1 (sr) 2024-06-28
RU2019103272A (ru) 2020-08-07
EP3482761A1 (fr) 2019-05-15
PL3482761T3 (pl) 2024-07-22
SI3482761T1 (sl) 2024-08-30
US20190240193A1 (en) 2019-08-08
MA45609A (fr) 2019-05-15
FI3482761T3 (fi) 2024-06-03
MX2019000136A (es) 2019-10-21
CN109715153A (zh) 2019-05-03

Similar Documents

Publication Publication Date Title
MA41013A (fr) Compositions comprenant des souches bactériennes
MA53937B1 (fr) Compositions comprenant des souches bactériennes
MA64509B1 (fr) Composés hétérocycliques utilisés comme immunomodulateurs
FR3028753B1 (fr) Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d&#39;agent viscosant, matifiant et/ou homogeneisant d&#39;application
MA64121B1 (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA46490A1 (fr) Dérivés de nucléosides 4&#39;- fluoro-2&#39; - méthyle substitués
MA41060B1 (fr) Compositions comprenant des souches bactériennes
MA55434B1 (fr) Compositions comprenant des souches bactériennes
MA67726B1 (fr) Utilisations thérapeutiques de dérivés deutérés du lanifibranor
MA42560A (fr) Compositions comprenant des souches bactériennes de blautia pour le traitement de l&#39;hypersensibilité viscérale
MA41010A (fr) Compositions comprenant des souches bactériennes
MA39783A (fr) Dérivés de quinoxaline utiles en tant que modulateurs de la fgfr kinase
MA43094A1 (fr) Dérivés de maytansinoïde, leurs conjugués, et procédés d&#39;utilisation
MA40893B1 (fr) Dérivés de phényltriazole à substitution hydroxyalkyle et utilisations associées
MA43335B1 (fr) Compositions d&#39;arni de transthyrétine (ttr) et procédés pour les utiliser pour le traitement ou la prévention de maladies associées à ttr
JOP20190193B1 (ar) ممركبات 2-أريل غير متجانس-3-أكسو-2، 3-ثنائي هيدرو بيريدازين-4-كربوكساميد لمعالجة السرطان
MA50406B1 (fr) Inhibiteurs pyrazole de magl
MA42410B1 (fr) Oxystérols et leurs méthodes d&#39;utilisation
MA47356B1 (fr) Dérivés d&#39;isochromène utiles en tant qu&#39;inhibiteurs des phosphoinositide 3-kinases
MA45598B1 (fr) Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda
MA43409B1 (fr) Composés polycycliques à utiliser en tant qu&#39;inhibiteurs de la tyrosine kinase de bruton
EP3695830A4 (fr) Utilisation d&#39;une composition comprenant des exosomes dérivés de cellules souches en tant que principe actif pour le renforcement et l&#39;amélioration fonctionnelle de la barrière cutanée
MA38810A1 (fr) Inhibiteurs de rorc2 méthodes d&#39;utilisation associées
MA38925A1 (fr) Dérivés de phénylalanine substitués
MA39337A1 (fr) Modulateurs de pyrazines de gpr6